Inventor
HUANMING CHEN
Inventor
CN
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
C07HSugars5%
Y02PClimate change mitigation technologies in the production or processing of goods5%
PatentTitleYear
12,492,170Tetrahydro-1H-benzazepine compound as potassium channel modulator, preparation method and use thereof202512,486,2652-aminopyrimidine compounds and pharmaceutical compositions and uses thereof202512,473,276Compound having neuroprotective effect, preparation method therefor and use thereof202512,319,656Compound as potassium channel regulator and preparation and use thereof202512,157,726P-phenylenediamine derivative as potassium channel regulator and preparation method and medical application thereof202411,365,181P-phenylenediamine derivative as potassium channel regulator and preparation method and medical application thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to SHANGHAI ZHIMENG BIOPHARMA INC (6)· patent assignee history
2022–2025Based in CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SHANGHAI ZHIMENG BIOPHARMA INC | 6 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 6 | 2022–2025 |